A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
about
The causal relation between human papillomavirus and cervical cancer.Overcoming Barriers to Cervical Cancer Screening Among Asian American WomenAccuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.External genital warts: diagnosis, treatment, and prevention.Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelScreening for cervical cancer: a review of women's attitudes, knowledge, and behaviourAntioxidant vitamins and lipid peroxidation in patients with cervical intraepithelial neoplasiaCytologic characteristics of abnormal cells in prior "normal" cervical/vaginal Papanicolaou smears from women with a high grade squamous intraepithelial lesion.Behavioral correlates of HPV vaccine acceptability in the 2007 Health Information National Trends Survey (HINTS)Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa.Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisComparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.Pathogenesis of genital HPV infection.HPV and p53 in cervical cancer.The detection of HPV DNA, the size of tampon specimens and the menstrual cycle.Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study.Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA.Effect of concurrent lower genital tract infections on cervical cancer screeningPrevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) GroupComparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.Comparison of variant-specific hybridization and single-strand conformational polymorphism methods for detection of mixed human papillomavirus type 16 variant infections.Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia.Th1 cytokine patterns in cervical human papillomavirus infection.Cell-mediated immune response to human papillomavirus infection.Good agreements between self and clinician-collected specimens for the detection of human papillomavirus in Brazilian patients.Have preferences of girls changed almost 3 years after the much debated start of the HPV vaccination program in The Netherlands? A discrete choice experiment.Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells.Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination
P2860
Q24673148-76DE8BD3-3DB6-489B-AEC3-1C5966AF6E17Q28389399-33FFB437-1615-4639-B6A1-5D99EB38ECA7Q30452566-B23CCCD3-8E42-4086-934B-EB3454017C96Q30658080-E500A3D6-CA9E-4223-8309-8C6A7F3A48F2Q30697527-C0559EDA-02FD-4677-B49B-5BC86101E7E9Q31112715-87720EEA-8AA7-49ED-92B5-BEDA674CA90BQ33292449-DC6C1239-C448-4E31-8783-5C426C6AB23CQ33488325-739B159D-1B12-41CD-997B-3364AD36EABCQ33534483-E471ED11-F133-453D-938D-A53398902298Q33599557-3854E270-3E3F-4808-9C80-F588B043339CQ33607646-5C4FFC92-FBF4-4071-9325-EB2FCA864933Q33645694-9D93098A-8D07-46D3-9C30-ED8CC73C9824Q33651617-7956A354-5F96-472D-979E-AD3CD45F6A9AQ33679334-3E2898D9-CAF2-45A8-9E66-415F6C55F8E0Q33683399-85D3C754-11E4-428B-9AEC-FDCA3C514779Q33698774-E7869D06-6C98-4282-83D6-A35A2749C199Q33725156-0F38BB06-EF85-49F2-BE1C-15349037AC6AQ33762765-058C6621-FB57-43D0-9722-D23088634894Q33852592-B077D3E6-CB80-4632-A970-4CC203444FCCQ33856287-1F9D5B3C-86BA-4A52-A2EB-DFD3847629A8Q33883532-BE0CE182-B931-49D3-9FB2-C60DBA1FB36FQ33885141-4853FA56-CF04-456D-BC50-B14DB4367950Q33934353-212AE527-9DE9-42A5-A0D7-005AEC7B2B92Q33934837-8395DA7B-1FFC-4603-B8D2-F13737CDFB1CQ33934843-84E11990-32BF-4CCE-A781-CE14DA8A87CDQ33934912-7C88DFFC-AC26-46D3-B46C-CA4E67F5C123Q33936598-B38D014A-31AE-41B4-96FC-B30B83187026Q33936898-70ADA2A2-84B8-49CB-8C5C-ABF7D89FC077Q33954679-C143855D-4D79-416B-BF12-870E8F0154F8Q33954692-29CDB4C5-4F0E-421A-9306-8740EE557441Q33963624-6F164827-BE6A-4C09-BC92-9F000EC63E7AQ33969680-C1DF9649-71F5-4459-A11A-ABA20CB12F04Q33974944-11CED84D-87D6-4231-B333-67886467B7D1Q33997914-1344B3EA-3DA9-4054-9DB8-683654390F8BQ33998922-07D232D7-273F-4AF2-9AF5-F928A66B98BCQ34040612-26D424B2-19BD-47CA-8A7A-FD1456D1AF99Q34066068-65518E47-CEF9-4652-A26F-7CDF10E09BC9Q34068144-48A11173-F8BF-4497-8F63-C7BBABF71F1FQ34152197-EB357FA4-F377-4405-ACB3-C8FABDD7D7BEQ34278627-55262C6F-5405-4AD9-BB5B-0523EA300E3E
P2860
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A cohort study of the risk of ...... n to papillomavirus infection.
@en
A cohort study of the risk of ...... n to papillomavirus infection.
@nl
type
label
A cohort study of the risk of ...... n to papillomavirus infection.
@en
A cohort study of the risk of ...... n to papillomavirus infection.
@nl
prefLabel
A cohort study of the risk of ...... n to papillomavirus infection.
@en
A cohort study of the risk of ...... n to papillomavirus infection.
@nl
P2093
P1476
A cohort study of the risk of ...... n to papillomavirus infection.
@en
P2093
Beckmann AM
Critchlow CW
DeRouen TA
Galloway DA
Koutsky LA
Paavonen J
Stevens CE
P304
P356
10.1056/NEJM199210293271804
P407
P577
1992-10-01T00:00:00Z